Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
Advances in Biological Regulation
|
December 13, 2022
Silencing effects of mutant RAS signalling on transcriptomes
Christine Sers, Reinhold Schäfer
Virchows Archiv : an International Journal of Pathology
|
June 1, 2006
Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review
Manfred Dietel, Christine Sers
Advances in Enzyme Regulation
|
November 25, 2010
RAS oncogene-mediated deregulation of the transcriptome: from molecular signature to function
Reinhold Schäfer, Christine Sers
Endocrine-Related Cancer
|
September 22, 2016
WOMEN IN CANCER THEMATIC REVIEW: Systemic therapies in neuroendocrine tumors and novel approaches toward personalized medicine
Marianne E Pavel, Christine Sers
Oncotarget
|
April 19, 2017
Robust in-silico identification of cancer cell lines based on next generation sequencing
Raik Otto, Christine Sers, Ulf Leser
Journal of Cell Science
|
March 22, 2007
Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
Irina Nazarenko, Reinhold Schäfer, Christine Sers
Bioinformatics Advances
|
January 8, 2024
BannMI deciphers potential <i>n</i>-to-1 information transduction in signaling pathways to unravel message of intrinsic apoptosis
Bettina Schmidt, Christine Sers, Nadja Klein
Molecular Genetics and Genomics : MGG
|
January 27, 2012
MsLDR-creator: a web service to design msLDR assays
Felix Bormann, Andreas Dahl, Christine Sers
FEBS Letters
|
December 9, 2008
Kinetic mechanisms for overexpression insensitivity and oncogene cooperation
Stefan Legewie, Christine Sers, Hanspeter Herzel
Cell Communication and Signaling : CCS
|
January 21, 2017
Unraveling the regulation of mTORC2 using logical modeling
Kirsten Thobe, Christine Sers, Heike Siebert
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
Advances in Biological Regulation
|
December 13, 2022
Silencing effects of mutant RAS signalling on transcriptomes
Christine Sers, Reinhold Schäfer
Virchows Archiv : an International Journal of Pathology
|
June 1, 2006
Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review
Manfred Dietel, Christine Sers
Advances in Enzyme Regulation
|
November 25, 2010
RAS oncogene-mediated deregulation of the transcriptome: from molecular signature to function
Reinhold Schäfer, Christine Sers
Endocrine-Related Cancer
|
September 22, 2016
WOMEN IN CANCER THEMATIC REVIEW: Systemic therapies in neuroendocrine tumors and novel approaches toward personalized medicine
Marianne E Pavel, Christine Sers
Oncotarget
|
April 19, 2017
Robust in-silico identification of cancer cell lines based on next generation sequencing
Raik Otto, Christine Sers, Ulf Leser
Journal of Cell Science
|
March 22, 2007
Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells
Irina Nazarenko, Reinhold Schäfer, Christine Sers
Bioinformatics Advances
|
January 8, 2024
BannMI deciphers potential <i>n</i>-to-1 information transduction in signaling pathways to unravel message of intrinsic apoptosis
Bettina Schmidt, Christine Sers, Nadja Klein
Molecular Genetics and Genomics : MGG
|
January 27, 2012
MsLDR-creator: a web service to design msLDR assays
Felix Bormann, Andreas Dahl, Christine Sers
FEBS Letters
|
December 9, 2008
Kinetic mechanisms for overexpression insensitivity and oncogene cooperation
Stefan Legewie, Christine Sers, Hanspeter Herzel
Cell Communication and Signaling : CCS
|
January 21, 2017
Unraveling the regulation of mTORC2 using logical modeling
Kirsten Thobe, Christine Sers, Heike Siebert
Page
of 12